Foroumadi A, Soltani F, Mirzaei M
The Research Center of Kerman University of Medical Sciences, Kerman, Iran.
Pharmazie. 2003 May;58(5):347-8.
A series of N-[2-(2-furyl)-2-oxoethyl], N-[2-(2-furyl)-2-oxyiminoethyl], N-[2-oxo-2-(2-thienyl)ethyl] and N-[2-oxyimino-2-(2-thienyl)ethyl] piperazinyl quinolones (1a-h; 2a-h) were evaluated for antituberculosis activity against M. tuberculosis H37Rv using the BACTEC 460 radiometric system and BACTEC 12B medium. Our results indicated that compounds 1a, 1e and 1g were efficient antimycobacterial agents showing MIC values ranging from 0.78 to 6.25 microg/ml. In general, ciprofloxacin derivatives were more active than norfloxacin derivatives and the oxime analogues were less active than corresponding ketones. Active compounds (1a, 1e and 1g) were also screened by serial dilution to assess toxicity to VERO cell line. The cytotoxicity of tested compounds indicated that compound 1a was the less toxic compound (IC50 > 62.5 microg/ml). This compound was tested for efficacy in vitro in TB-infected macrophage model (EC90 = 3.25 microg/ml).
使用BACTEC 460放射测量系统和BACTEC 12B培养基,对一系列N-[2-(2-呋喃基)-2-氧代乙基]、N-[2-(2-呋喃基)-2-氧基亚氨基乙基]、N-[2-氧代-2-(2-噻吩基)乙基]和N-[2-氧基亚氨基-2-(2-噻吩基)乙基]哌嗪基喹诺酮类化合物(1a-h;2a-h)进行了抗结核分枝杆菌H37Rv活性评估。我们的结果表明,化合物1a、1e和1g是有效的抗分枝杆菌剂,MIC值范围为0.78至6.25微克/毫升。总体而言,环丙沙星衍生物比诺氟沙星衍生物更具活性,肟类似物比相应的酮活性更低。还通过系列稀释法对活性化合物(1a、1e和1g)进行筛选,以评估其对VERO细胞系的毒性。受试化合物的细胞毒性表明,化合物1a是毒性较小的化合物(IC50>62.5微克/毫升)。在结核感染的巨噬细胞模型中对该化合物进行了体外疗效测试(EC90 = 3.25微克/毫升)。